Capstone Investment Advisors’s Verona Pharma VRNA Stock Holding History

Capstone Investment Advisors’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-375,000	Closed	-$40M	–	2083
2025 Q3	$40M	Buy	+375,000	New	+$39.2M	0.07%	123
2024 Q2	–	Sell	-25,616	Closed	-$412K	–	2508
2024 Q1	$412K	Buy	+25,616	New	+$443K	﹤0.01%	1663

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Capstone Investment Advisors's VRNA Position: Q4 2025 in Review

Capstone Investment Advisors sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 375,000 shares — an estimated $40M sold.

Capstone Investment Advisors first reported a position in VRNA in Q1 2024 and held it in 2 quarters. The position peaked at $40M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Capstone Investment Advisors reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Capstone Investment Advisors sold 375,000 Verona Pharma shares in Q4 2025, an estimated $40M.
Capstone Investment Advisors first reported a position in Verona Pharma in Q1 2024 and held it in 2 quarters.
Capstone Investment Advisors's Verona Pharma position peaked at $40M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Capstone Investment Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.